Literature DB >> 29616307

Extracellular vesicles and their immunomodulatory functions in pregnancy.

Soumyalekshmi Nair1, Carlos Salomon2,3.   

Abstract

Extracellular vesicles (EVs) are membrane-bound vesicles released into the extracellular space by almost all types of cells. EVs can cross the physiological barriers, and a variety of biological fluids are enriched in them. EVs are a heterogeneous population of vesicles, including exosomes, microvesicles, and apoptotic bodies. The different subpopulations of vesicles can be differentiated by size and origin, in which exosomes (~100 nm and from endocytic origin) are the most studied so far. EVs have essential roles in cell-to-cell communication and are critical modulators of immune response under normal and pathological conditions. Pregnancy is a unique situation of immune-modulation in which the maternal immune system protects the fetus from allogenic rejection and maintains the immunosurveillance. The placenta is a vital organ that performs a multitude of functions to support the pregnancy. The EVs derived from the human placenta have crucial roles in regulating the maternal immune response for successful pregnancy outcome. Placenta-derived vesicles perform a myriad of functions like suppression of immune reaction to the developing fetus and establishment and maintenance of a systemic inflammatory response to combat infectious intruders. A fine-tuning of these mechanisms is quintessential for successful completion of pregnancy and healthy outcome for mother and fetus. Dysregulation in the mechanisms mentioned above can lead to several pregnancy disorders. In this review, we summarize the current literature regarding the critical roles played by the EVs in immunomodulation during pregnancy with particular attention to the placenta-derived exosomes.

Entities:  

Keywords:  Exosomes; Extracellular vesicles; Immune response; Pregnancy

Mesh:

Year:  2018        PMID: 29616307     DOI: 10.1007/s00281-018-0680-2

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  99 in total

1.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.

Authors:  L Zitvogel; A Regnault; A Lozier; J Wolfers; C Flament; D Tenza; P Ricciardi-Castagnoli; G Raposo; S Amigorena
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

2.  Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women.

Authors:  Claudia M Radu; Elena Campello; Luca Spiezia; Sonila Dhima; Silvia Visentin; Sabrina Gavasso; Barry Woodhams; Erich Cosmi; Paolo Simioni
Journal:  Scand J Clin Lab Invest       Date:  2015-06-12       Impact factor: 1.713

Review 3.  A leading role for the immune system in the pathophysiology of preeclampsia.

Authors:  Estibalitz Laresgoiti-Servitje
Journal:  J Leukoc Biol       Date:  2013-04-30       Impact factor: 4.962

4.  High levels of circulating extracellular vesicles with altered expression and function during pregnancy.

Authors:  Fabiola da Silva Nardi; Tatiana Ferreira Michelon; Jorge Neumann; Luis Felipe Santos Manvailer; Bettina Wagner; Peter A Horn; Maria da Graça Bicalho; Vera Rebmann
Journal:  Immunobiology       Date:  2016-03-15       Impact factor: 3.144

5.  The endogenous retroviral envelope protein syncytin-1 inhibits LPS/PHA-stimulated cytokine responses in human blood and is sorted into placental exosomes.

Authors:  J M Tolosa; J E Schjenken; V L Clifton; A Vargas; B Barbeau; P Lowry; K Maiti; R Smith
Journal:  Placenta       Date:  2012-09-20       Impact factor: 3.481

6.  Isolation of human trophoblastic extracellular vesicles and characterization of their cargo and antiviral activity.

Authors:  Yingshi Ouyang; Avraham Bayer; Tianjiao Chu; Vladimir A Tyurin; Valerian E Kagan; Adrian E Morelli; Carolyn B Coyne; Yoel Sadovsky
Journal:  Placenta       Date:  2016-09-14       Impact factor: 3.481

7.  Induction of pregnancy during established EAE halts progression of CNS autoimmune injury via pregnancy-specific serum factors.

Authors:  Natosha N Gatson; Jessica L Williams; Nicole D Powell; Melanie A McClain; Teresa R Hennon; Paul D Robbins; Caroline C Whitacre
Journal:  J Neuroimmunol       Date:  2010-10-14       Impact factor: 3.478

8.  Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level.

Authors:  L Frängsmyr; V Baranov; O Nagaeva; U Stendahl; L Kjellberg; L Mincheva-Nilsson
Journal:  Mol Hum Reprod       Date:  2004-12-03       Impact factor: 4.025

9.  Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success.

Authors:  Lucia Mincheva-Nilsson; Vladimir Baranov
Journal:  Am J Reprod Immunol       Date:  2014-08-28       Impact factor: 3.886

10.  Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles.

Authors:  Sarah J Germain; Gavin P Sacks; Suren R Sooranna; Suren R Soorana; Ian L Sargent; Christopher W Redman
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

View more
  28 in total

1.  Putting EV into context: contextual factors influencing immune-related functions of extracellular vesicles (EV).

Authors:  Esther Nolte-'t Hoen
Journal:  Semin Immunopathol       Date:  2018-10-23       Impact factor: 9.623

2.  Quantitative Proteomics by SWATH-MS of Maternal Plasma Exosomes Determine Pathways Associated With Term and Preterm Birth.

Authors:  Ramkumar Menon; Christopher Luke Dixon; Samantha Sheller-Miller; Stephen J Fortunato; George R Saade; Carlos Palma; Andrew Lai; Dominic Guanzon; Carlos Salomon
Journal:  Endocrinology       Date:  2019-03-01       Impact factor: 4.736

Review 3.  The exosome: a review of current therapeutic roles and capabilities in human reproduction.

Authors:  Marko Dimik; Pevindu Abeysinghe; Jayden Logan; Murray Mitchell
Journal:  Drug Deliv Transl Res       Date:  2022-08-18       Impact factor: 5.671

4.  Single extracellular vesicle analysis in human amniotic fluid shows evidence of phenotype alterations in preeclampsia.

Authors:  Natalia Gebara; Julia Scheel; Renata Skovronova; Cristina Grange; Luca Marozio; Shailendra Gupta; Veronica Giorgione; Federico Caicci; Chiara Benedetto; Asma Khalil; Benedetta Bussolati
Journal:  J Extracell Vesicles       Date:  2022-05

Review 5.  Synergies of Extracellular Vesicles and Microchimerism in Promoting Immunotolerance During Pregnancy.

Authors:  José M Murrieta-Coxca; Paulina Fuentes-Zacarias; Stephanie Ospina-Prieto; Udo R Markert; Diana M Morales-Prieto
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

Review 6.  Extracellular vesicles and immune response during pregnancy: A balancing act.

Authors:  Adrian E Morelli; Yoel Sadovsky
Journal:  Immunol Rev       Date:  2022-02-23       Impact factor: 10.983

7.  Specific innate immune cells uptake fetal antigen and display homeostatic phenotypes in the maternal circulation.

Authors:  Marcia Arenas-Hernandez; Roberto Romero; Meyer Gershater; Li Tao; Yi Xu; Valeria Garcia-Flores; Errile Pusod; Derek Miller; Jose Galaz; Kenichiro Motomura; George Schwenkel; Robert Para; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2021-12-10       Impact factor: 6.011

Review 8.  Placental programming of neuropsychiatric disease.

Authors:  Panagiotis Kratimenos; Anna A Penn
Journal:  Pediatr Res       Date:  2019-04-19       Impact factor: 3.756

Review 9.  Placental extracellular vesicles and pre-eclampsia.

Authors:  Jessica Schuster; Shi-Bin Cheng; James Padbury; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2020-07-18       Impact factor: 3.886

10.  Systemic Characterization of Novel Immune Cell Phenotypes in Recurrent Pregnancy Loss.

Authors:  Hong Liu; Xin-Xiu Lin; Xiao-Bo Huang; Dong-Hui Huang; Su Song; Yang-Jiao Chen; Jing Tang; Ding Tao; Zhi-Nan Yin; Gil Mor; Ai-Hua Liao
Journal:  Front Immunol       Date:  2021-05-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.